Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.11851/12134
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSalahshoori, I.-
dc.contributor.authorMobaraki-Asl, N.-
dc.contributor.authorSeyfaee, A.-
dc.contributor.authorMirzaei Nasirabad, N.-
dc.contributor.authorDehghan, Z.-
dc.contributor.authorFaraji, M.-
dc.contributor.authorHamrang, A.-
dc.date.accessioned2025-03-22T20:55:30Z-
dc.date.available2025-03-22T20:55:30Z-
dc.date.issued2021-
dc.identifier.issn2673-8449-
dc.identifier.urihttps://doi.org/10.3390/biologics1010002-
dc.identifier.urihttps://hdl.handle.net/20.500.11851/12134-
dc.description.abstractCoronaviruses belong to the “Coronaviridae family”, which causes various diseases, from the common cold to SARS and MERS. The coronavirus is naturally prevalent in mammals and birds. So far, six human-transmitted coronaviruses have been discovered. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019 in Wuhan, China. Common symptoms include fever, dry cough, and fatigue, but in acute cases, the disease can lead to severe shortness of breath, hypoxia, and death. According to the World Health Organization (WHO), the three main transmission routes, such as droplet and contact routes, airborne transmission and fecal and oral for COVID-19, have been identified. So far, no definitive curative treatment has been discovered for COVID-19, and the available treatments are only to reduce the complications of the disease. According to the World Health Organization, preventive measures at the public health level such as quarantine of the infected person, identification and monitoring of contacts, disinfection of the environment, and personal protective equipment can significantly prevent the outbreak COVID-19. Currently, based on the urgent needs of the community to control this pandemic, the BNT162b2 (Pfizer), mRNA-1273 (Moderna), CoronaVac (Sinovac), Sputnik V (Gamaleya Research Institute, Acellena Contract Drug Research, and Development), BBIBP-CorV (Sinofarm), and AZD1222 (The University of Oxford; AstraZeneca) vaccines have received emergency vaccination licenses from health organizations in vaccine-producing countries. Vasso Apostolopoulos, Majid Hassanzadeganroudsari © 2021 by the authors.en_US
dc.language.isoenen_US
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)en_US
dc.relation.ispartofBiologicsen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCoronavirusen_US
dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2)en_US
dc.subjectVaccinesen_US
dc.titleOverview of Covid-19 Disease: Virology, Epidemiology, Prevention Diagnosis, Treatment, and Vaccinesen_US
dc.typeArticleen_US
dc.departmentTOBB University of Economics and Technologyen_US
dc.identifier.volume1en_US
dc.identifier.issue1en_US
dc.identifier.startpage2en_US
dc.identifier.endpage40en_US
dc.identifier.scopus2-s2.0-85119472834-
dc.identifier.doi10.3390/biologics1010002-
dc.authorscopusid57212004772-
dc.authorscopusid59340428800-
dc.authorscopusid35622540700-
dc.authorscopusid59340733300-
dc.authorscopusid58390751500-
dc.authorscopusid57215436031-
dc.authorscopusid59340521500-
dc.relation.publicationcategoryDiğeren_US
dc.identifier.scopusqualityN/A-
dc.identifier.wosqualityN/A-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeArticle-
item.grantfulltextnone-
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

20
checked on Mar 29, 2025

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.